期刊
KIDNEY INTERNATIONAL
卷 79, 期 1, 页码 33-45出版社
ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2010.337
关键词
aminoglycoside antibiotics; gentamicin; nephrotoxicity; pathophysiology; prevention
资金
- Instituto de Salud Carlos III [016/2006, PI081900]
- Junta de Castilla y Leon (Excellence Group) [GR-100]
- Ministerio de Ciencia y Tecnologia [BFU2004-00285/BFI, SAF2007-63893]
Nephrotoxicity is one of the most important side effects and therapeutical limitations of aminoglycoside antibiotics, especially gentamicin. Despite rigorous patient monitoring, nephrotoxicity appears in 10-25% of therapeutic courses. Traditionally, aminoglycoside nephrotoxicity has been considered to result mainly from tubular damage. Both lethal and sub-lethal alterations in tubular cells handicap reabsorption and, in severe cases, may lead to a significant tubular obstruction. However, a reduced glomerular filtration is necessary to explain the symptoms of the disease. Reduced filtration is not solely the result of tubular obstruction and tubular malfunction, resulting in tubuloglomerular feedback activation; renal vasoconstriction and mesangial contraction are also crucial to fully explain aminoglycoside nephrotoxicity. This review critically presents an integrative view on the interactions of tubular, glomerular, and vascular effects of gentamicin, in the context of the most recent information available. Moreover, it discusses therapeutic perspectives for prevention of aminoglycoside nephrotoxicity derived from the pathophysiological knowledge. Kidney International (2011) 79, 33-45; doi: 10.1038/ki.2010.337; published online 22 September 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据